Xenon Pharmaceuticals IncNASDAQ:XENE
- LAST PRICE38.0700
- TODAY'S CHANGE (%)-0.9700 (-2.4846%)
- Bid / Lots35.0000/ 1
- Ask / Lots50.0000/ 1
- Open / Previous Close39.1600 / 39.0400
- Day Range
- 52 Week Range
- Volume778,149
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | XENE |
|---|---|---|
| 09:32 ET | 1016 | 39.6999 |
| 09:34 ET | 100 | 39.17 |
| 09:36 ET | 100 | 39.15 |
| 09:38 ET | 3472 | 39.305 |
| 09:41 ET | 100 | 39.185 |
| 09:43 ET | 1213 | 39.645 |
| 09:45 ET | 303 | 39.683 |
| 09:54 ET | 700 | 39.56 |
| 09:56 ET | 700 | 39.555 |
| 09:57 ET | 1000 | 39.42 |
| 09:59 ET | 2629 | 39.68 |
| 10:01 ET | 356 | 39.48 |
| 10:08 ET | 100 | 39.185 |
| 10:10 ET | 200 | 39.22 |
| 10:14 ET | 210 | 39.01 |
| 10:15 ET | 100 | 39.02 |
| 10:17 ET | 204 | 39 |
| 10:19 ET | 5183 | 38.74 |
| 10:26 ET | 672 | 38.72 |
| 10:28 ET | 100 | 38.58 |
| 10:30 ET | 100 | 38.56 |
| 10:33 ET | 509 | 38.66 |
| 10:35 ET | 200 | 38.655 |
| 10:37 ET | 100 | 38.59 |
| 10:39 ET | 1173 | 38.685 |
| 10:42 ET | 300 | 38.66 |
| 10:44 ET | 100 | 38.565 |
| 10:46 ET | 200 | 38.5 |
| 10:48 ET | 475 | 38.41 |
| 10:53 ET | 200 | 38.44 |
| 10:57 ET | 711 | 38.535 |
| 11:00 ET | 819 | 38.54 |
| 11:02 ET | 147 | 38.54 |
| 11:04 ET | 955 | 38.545 |
| 11:06 ET | 838 | 38.5152 |
| 11:11 ET | 500 | 38.75 |
| 11:13 ET | 200 | 38.7 |
| 11:15 ET | 200 | 38.65 |
| 11:18 ET | 195 | 38.675 |
| 11:20 ET | 200 | 38.6 |
| 11:22 ET | 300 | 38.56 |
| 11:26 ET | 100 | 38.57 |
| 11:29 ET | 240 | 38.54 |
| 11:33 ET | 359 | 38.58 |
| 11:36 ET | 200 | 38.6 |
| 11:38 ET | 100 | 38.53 |
| 11:40 ET | 19263 | 38.54 |
| 11:42 ET | 525 | 38.55 |
| 11:44 ET | 200 | 38.54 |
| 11:45 ET | 535 | 38.59 |
| 11:47 ET | 700 | 38.59 |
| 11:49 ET | 485 | 38.66 |
| 11:51 ET | 867 | 38.6 |
| 11:54 ET | 100 | 38.6 |
| 12:07 ET | 1693 | 38.57 |
| 12:14 ET | 1147 | 38.595 |
| 12:16 ET | 200 | 38.665 |
| 12:18 ET | 104 | 38.665 |
| 12:21 ET | 200 | 38.59 |
| 12:25 ET | 110 | 38.5691 |
| 12:27 ET | 200 | 38.54 |
| 12:30 ET | 300 | 38.54 |
| 12:32 ET | 100 | 38.54 |
| 12:34 ET | 100 | 38.54 |
| 12:36 ET | 200 | 38.54 |
| 12:38 ET | 408 | 38.57 |
| 12:39 ET | 460 | 38.58 |
| 12:41 ET | 200 | 38.54 |
| 12:43 ET | 300 | 38.54 |
| 12:45 ET | 535 | 38.54 |
| 12:48 ET | 100 | 38.54 |
| 12:50 ET | 100 | 38.54 |
| 12:52 ET | 200 | 38.57 |
| 12:54 ET | 711 | 38.57 |
| 12:56 ET | 200 | 38.57 |
| 12:57 ET | 300 | 38.54 |
| 12:59 ET | 100 | 38.54 |
| 01:01 ET | 100 | 38.54 |
| 01:03 ET | 825 | 38.62 |
| 01:06 ET | 200 | 38.59 |
| 01:08 ET | 200 | 38.54 |
| 01:10 ET | 698 | 38.6 |
| 01:12 ET | 100 | 38.54 |
| 01:14 ET | 300 | 38.56 |
| 01:15 ET | 107388 | 38.355 |
| 01:17 ET | 3389 | 38.36 |
| 01:19 ET | 300 | 38.36 |
| 01:21 ET | 200 | 38.38 |
| 01:24 ET | 100 | 38.37 |
| 01:28 ET | 700 | 38.37 |
| 01:30 ET | 100 | 38.41 |
| 01:32 ET | 983 | 38.25 |
| 01:33 ET | 100 | 38.22 |
| 01:35 ET | 700 | 38.05 |
| 01:37 ET | 1151 | 38.06 |
| 01:39 ET | 1400 | 38.18 |
| 01:42 ET | 1617 | 38.38 |
| 01:44 ET | 200 | 38.315 |
| 01:46 ET | 530 | 38.305 |
| 01:48 ET | 300 | 38.25 |
| 01:50 ET | 200 | 38.22 |
| 01:51 ET | 200 | 38.32 |
| 01:53 ET | 200 | 38.28 |
| 01:55 ET | 200 | 38.32 |
| 01:57 ET | 400 | 38.185 |
| 02:00 ET | 300 | 38.19 |
| 02:02 ET | 400 | 38.28 |
| 02:04 ET | 300 | 38.23 |
| 02:06 ET | 1268 | 38.32 |
| 02:08 ET | 100 | 38.25 |
| 02:09 ET | 700 | 38.23 |
| 02:11 ET | 300 | 38.15 |
| 02:13 ET | 100 | 38.15 |
| 02:15 ET | 600 | 38.205 |
| 02:18 ET | 747 | 38.15 |
| 02:20 ET | 100 | 38.15 |
| 02:22 ET | 1317 | 38.27 |
| 02:24 ET | 300 | 38.21 |
| 02:26 ET | 1136 | 38.37 |
| 02:27 ET | 1494 | 38.24 |
| 02:29 ET | 200 | 38.25 |
| 02:31 ET | 200 | 38.25 |
| 02:33 ET | 100 | 38.25 |
| 02:36 ET | 300 | 38.25 |
| 02:38 ET | 500 | 38.265 |
| 02:40 ET | 1743 | 38.32 |
| 02:42 ET | 1487 | 38.35 |
| 02:44 ET | 500 | 38.345 |
| 02:45 ET | 200 | 38.35 |
| 02:47 ET | 400 | 38.37 |
| 02:49 ET | 2200 | 38.41 |
| 02:51 ET | 1216 | 38.28 |
| 02:54 ET | 400 | 38.275 |
| 02:56 ET | 200 | 38.29 |
| 02:58 ET | 620 | 38.305 |
| 03:00 ET | 100 | 38.31 |
| 03:02 ET | 900 | 38.34 |
| 03:03 ET | 8664 | 38.1 |
| 03:05 ET | 1379 | 37.96 |
| 03:07 ET | 400 | 37.98 |
| 03:09 ET | 612 | 38.04 |
| 03:12 ET | 474 | 38.02 |
| 03:14 ET | 494 | 37.97 |
| 03:16 ET | 594 | 37.93 |
| 03:18 ET | 800 | 38.01 |
| 03:20 ET | 300 | 37.94 |
| 03:21 ET | 700 | 37.91 |
| 03:23 ET | 1550 | 38.03 |
| 03:25 ET | 600 | 37.99 |
| 03:27 ET | 800 | 38 |
| 03:30 ET | 400 | 37.97 |
| 03:32 ET | 400 | 37.79 |
| 03:34 ET | 1530 | 37.87 |
| 03:36 ET | 2125 | 37.855 |
| 03:38 ET | 2536 | 37.66 |
| 03:39 ET | 2818 | 37.655 |
| 03:41 ET | 1049 | 37.66 |
| 03:43 ET | 1628 | 37.58 |
| 03:45 ET | 3536 | 37.61 |
| 03:48 ET | 2086 | 37.61 |
| 03:50 ET | 6153 | 37.88 |
| 03:52 ET | 5002 | 37.79 |
| 03:54 ET | 3477 | 37.795 |
| 03:56 ET | 4824 | 38.08 |
| 03:57 ET | 4712 | 38.12 |
| 03:59 ET | 3769 | 38.07 |
May 28, 2024
May 10, 2024
DJ Xenon Pharmaceuticals Is Maintained at Buy by Needham, from 6:12PM ET on Friday May 10, 2024 by Dow Jones
6:12PM ET on Friday May 10, 2024 by Dow JonesDJ Xenon Pharmaceuticals Is Maintained at Buy by Citigroup, from 5:48PM ET on Friday May 10, 2024 by Dow Jones
5:48PM ET on Friday May 10, 2024 by Dow JonesDJ Xenon Pharmaceuticals Is Maintained at Outperform by Wedbush, from 9:30AM ET on Friday May 10, 2024 by Dow Jones
9:30AM ET on Friday May 10, 2024 by Dow Jones
May 9, 2024
Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update, from 4:01PM ET on Thursday May 09, 2024 by Dow Jones
4:01PM ET on Thursday May 09, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Xenon Pharmaceuticals Inc | 2.9B | -14.0x | --- |
Janux Therapeutics Inc | 2.8B | -43.7x | --- |
Apogee Therapeutics Inc | 2.7B | -22.3x | --- |
Biohaven Ltd | 3.1B | -5.1x | --- |
SpringWorks Therapeutics Inc | 3.1B | -8.1x | --- |
Dyne Therapeutics Inc | 3.1B | -8.0x | --- |
Company Information
Xenon Pharmaceuticals Inc. is a Canada-based clinical-stage biopharmaceutical company focused on developing therapeutics to improve the lives of patients with neurological disorders, with a focus on epilepsy. The Company’s product pipeline includes XEN1101 (Focal Onset Seizures), XEN1101 (Primary Generalized Tonic-Clonic Seizures), XEN1101 (Major Depressive Disorder) and NBI-921352 (NEUROCRINE). It is developing XEN1101, a differentiated Kv7 potassium channel opener, for the treatment of epilepsy, MDD and potentially other neurological disorders. Its XEN1101 Phase III epilepsy program includes two identical Phase III clinical trials, called X-TOLE2 and X-TOLE3, that are designed closely after the Phase IIb X-TOLE clinical trial. Its Phase III X-ACKT clinical trial is intended to support potential regulatory submissions in an additional epilepsy indication of primary generalized tonic-clonic seizures (PGTCS).
Contact Information
- Headquarters
- 3650 Gilmore WayVANCOUVER, BC, Canada V5G 4W8
- Phone
- 604-484-3300
- Fax
- 604-484-3450
Executives
- Chairman of the Board
- Simon Pimstone
- President, Chief Executive Officer, Director
- Ian Mortimer
- Chief Financial Officer
- Sherry Aulin
- Executive Vice President - Drug Discovery
- James Empfield
- Executive Vice President - Strategy and Innovation
- Robin Sherrington
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.9B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 75.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.22 |
EPS | $-2.71 |
Book Value | $12.31 |
P/E Ratio | -14.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
